Early diagnosis of prostatic cancer: disease-related survival improvement or extension of observation time?
It is well recognized that prostate cancer represents the most common cancer in men in western countries and it is the second leading cause of cancer death. Although prostate cancer detection has improved, we still have to establish to what extent our diagnostic tools are correlated with the clinical prognosis. This task of distinguishing more aggressive disease from relatively benign cases remains a major goal. The findings of ongoing randomised screening studies should aid us in this task, so that we can avoid the treatment of those who do not need it and tailor our treatment strategy more closely to the individual prognosis.